RetinalGenix Technologies (RTGN) Net Cash Flow (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Net Cash Flow of -$14594.0 for Q1 2026, down 199.4% sequentially from $14682.0 in Q4 2025, and down 521.29% YoY from $3464.2 in Q1 2025.
RetinalGenix Technologies (RTGN) Net Cash Flow (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Net Cash Flow for 7 years, with the latest figure at -$14594.0 in Q1 2026.
- Quarterly Net Cash Flow fell 521.29% year-over-year to -$14594.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3531.0 (up 92.43% YoY) and the FY2025 annual result came in at $8714.0, up 43.8% from the prior year.
- Net Cash Flow eased to -$14594.0 in Q1 2026 per RTGN's latest filing, from $14682.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $50386.0 in Q1 2024 and troughed at -$73029.0 in Q4 2024.
- A 5-year average of -$262.35 and a median of -$2349.0 in 2025 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 757.32% in 2024, down 165875.0% in 2024.
- Over 5 years, Net Cash Flow stood at -$3574.0 in 2022, then surged by 98.77% to -$44.0 in 2023, then slumped by 165875.0% to -$73029.0 in 2024, then soared by 120.1% to $14682.0 in 2025, then plunged by 199.4% to -$14594.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$14594.0, $14682.0, and -$747.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -14,594.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,594.00 |
| Mar 31, 2026 | -14,594.00 |
| Dec 31, 2025 | 14,682.00 |
| Dec 31, 2025 | 14,682.00 |
| Sep 30, 2025 | -747.00 |
| Sep 30, 2025 | -747.00 |
| Jun 30, 2025 | -2,872.00 |
| Jun 30, 2025 | -2,872.00 |
| Mar 31, 2025 | -2,349.00 |
| Mar 31, 2025 | -2,349.00 |
| Dec 31, 2024 | -73,029.00 |
| Dec 31, 2024 | -73,029.00 |
| Sep 30, 2024 | -7,824.00 |
| Sep 30, 2024 | -7,824.00 |
| Jun 30, 2024 | 36,527.00 |
| Jun 30, 2024 | 36,527.00 |
| Mar 31, 2024 | 50,386.00 |
| Mar 31, 2024 | 50,386.00 |
| Dec 31, 2023 | -44.00 |
| Dec 31, 2023 | -44.00 |